tiprankstipranks
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market
MDGL
Madrigal Pharmaceuticals
RESEARCH TOOLSreports
Want to see MDGL full AI Analyst Report?

Madrigal Pharmaceuticals (MDGL) Ratios

1,356 Followers

Madrigal Pharmaceuticals Ratios

MDGL's free cash flow for Q2 2026 was $0.89. For the 2026 fiscal year, MDGL's free cash flow was decreased by $ and operating cash flow was $-0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.20 4.01 6.10 5.38 3.12
Quick Ratio
 2.94 3.77 5.90 5.38 3.12
Cash Ratio
 0.78 0.64 0.59 0.84 2.86
Solvency Ratio
 -0.45 -0.44 -1.61 -1.59 -1.79
Operating Cash Flow Ratio
 -0.53 -0.61 -2.69 -2.74 -1.94
Short-Term Operating Cash Flow Coverage
 -191.21 -186.20 0.00 0.00 0.00
Net Current Asset Value
$ 478.26M$ 588.87M$ 745.06M$ 402.07M$ 196.19M
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.28 0.11 0.18 0.14
Debt-to-Equity Ratio
 0.66 0.59 0.16 0.29 0.25
Debt-to-Capital Ratio
 0.40 0.37 0.14 0.22 0.20
Long-Term Debt-to-Capital Ratio
 0.39 0.37 0.13 0.22 0.20
Financial Leverage Ratio
 2.38 2.09 1.38 1.58 1.84
Debt Service Coverage Ratio
 -17.93 -11.34 -30.68 -28.35 -73.39
Interest Coverage Ratio
 -20.64 -13.45 -33.94 -29.93 -74.06
Debt to Market Cap
 0.03 0.03 0.02 0.03 <0.01
Interest Debt Per Share
 12.47 16.79 6.31 6.95 3.14
Net Debt to EBITDA
 -0.18 -0.59 -0.04 -0.05 0.97
Profitability Margins
Gross Profit Margin
91.48%94.14%96.54%0.00%0.00%
EBIT Margin
-23.36%-27.75%-250.49%0.00%0.00%
EBITDA Margin
-23.27%-27.59%-249.88%0.00%0.00%
Operating Profit Margin
-25.13%-31.31%-276.39%0.00%0.00%
Pretax Profit Margin
-25.32%-30.08%-258.64%0.00%0.00%
Net Profit Margin
-25.32%-30.08%-258.64%0.00%0.00%
Continuous Operations Profit Margin
-25.32%-30.08%-258.64%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
100.77%96.06%93.58%98.20%100.61%
Return on Assets (ROA)
-26.12%-22.89%-44.70%-58.33%-81.46%
Return on Equity (ROE)
-56.65%-47.83%-61.76%-92.18%-149.63%
Return on Capital Employed (ROCE)
-37.06%-31.61%-57.03%-72.89%-119.01%
Return on Invested Capital (ROIC)
-37.02%-31.58%-56.97%-72.82%-118.72%
Return on Tangible Assets
-26.27%-23.02%-44.90%-58.33%-81.46%
Earnings Yield
-2.07%-2.21%-7.10%-8.64%-5.94%
Efficiency Ratios
Receivables Turnover
 6.68 7.13 3.35 0.00 0.00
Payables Turnover
 3.17 1.15 0.14 0.00 0.00
Inventory Turnover
 1.10 0.75 0.18 0.00 0.00
Fixed Asset Turnover
 74.78 148.87 39.24 0.00 0.00
Asset Turnover
 1.03 0.76 0.17 0.00 0.00
Working Capital Turnover Ratio
 1.54 1.07 0.26 0.00 0.00
Cash Conversion Cycle
 271.08 219.99 -449.07 0.00 0.00
Days of Sales Outstanding
 54.67 51.21 109.06 0.00 0.00
Days of Inventory Outstanding
 331.53 486.52 1.99K 0.00 0.00
Days of Payables Outstanding
 115.13 317.74 2.55K 0.00 0.00
Operating Cycle
 386.20 537.73 2.10K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -6.78 -8.45 -21.42 -17.35 -13.12
Free Cash Flow Per Share
 -7.08 -8.47 -21.48 -17.43 -13.13
CapEx Per Share
 0.29 0.02 0.07 0.08 0.01
Free Cash Flow to Operating Cash Flow
 1.04 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -23.07 -405.90 -311.61 -219.22 -1.04K
Capital Expenditure Coverage Ratio
 -23.07 -405.90 -311.61 -219.22 -1.04K
Operating Cash Flow Coverage Ratio
 -0.57 -0.53 -3.81 -2.77 -4.51
Operating Cash Flow to Sales Ratio
 -0.15 -0.20 -2.53 0.00 0.00
Free Cash Flow Yield
-1.65%-1.45%-6.96%-7.53%-4.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -41.90 -45.32 -14.09 -11.57 -16.84
Price-to-Sales (P/S) Ratio
 9.72 13.63 36.44 0.00 0.00
Price-to-Book (P/B) Ratio
 30.05 21.68 8.70 10.67 25.20
Price-to-Free Cash Flow (P/FCF) Ratio
 -60.49 -68.75 -14.36 -13.28 -22.10
Price-to-Operating Cash Flow Ratio
 -79.61 -68.92 -14.41 -13.34 -22.12
Price-to-Earnings Growth (PEG) Ratio
 121.38 1.10 -1.47 -0.72 -0.95
Price-to-Fair Value
 30.05 21.68 8.70 10.67 25.20
Enterprise Value Multiple
 -41.95 -49.99 -14.63 -12.05 -16.13
Enterprise Value
 12.53B 13.22B 6.58B 4.34B 4.69B
EV to EBITDA
 -41.95 -49.99 -14.63 -12.05 -16.13
EV to Sales
 9.76 13.79 36.55 0.00 0.00
EV to Free Cash Flow
 -60.75 -69.57 -14.41 -13.33 -20.85
EV to Operating Cash Flow
 -63.39 -69.74 -14.45 -13.39 -20.87
Tangible Book Value Per Share
 17.72 26.54 35.24 21.69 11.52
Shareholders’ Equity Per Share
 17.97 26.86 35.46 21.69 11.52
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 44.05 42.72 8.47 0.00 0.00
Net Income Per Share
 -11.15 -12.85 -21.90 -19.99 -17.23
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.08 1.08 1.03 1.04 1.01
Research & Development to Revenue
 0.38 0.41 1.31 0.00 0.00
SG&A to Revenue
 0.78 0.85 2.42 0.00 0.00
Stock-Based Compensation to Revenue
 0.07 0.10 0.44 0.00 0.00
Income Quality
 0.61 0.66 0.98 0.87 0.76
Currency in USD